Anthony Scaramucci and Brittany Kaiser explain how AlphaTON are using digital assets to fund cancer research and launch companies within blockchain and the “Telegram ecosystem.” AlphaTON (ATON) owns multiple molecules and is looking for “innovative ways” to combine their biotech knowledge with financial systems expertise. Brittany notes that it is hard to raise money for biotech right now, but it’s easy to fundraise for digital assets.